Literature DB >> 21827967

A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins.

Andrei P Pomerantsev1, Olga M Pomerantseva, Mahtab Moayeri, Rasem Fattah, Cynthia Tallant, Stephen H Leppla.   

Abstract

Bacillus anthracis produces a number of extracellular proteases that impact the integrity and yield of other proteins in the B. anthracis secretome. In this study we show that anthrolysin O (ALO) and the three anthrax toxin proteins, protective antigen (PA), lethal factor (LF), and edema factor (EF), produced from the B. anthracis Ames 35 strain (pXO1⁺, pXO2⁻), are completely degraded at the onset of stationary phase due to the action of proteases. An improved Cre-loxP gene knockout system was used to sequentially delete the genes encoding six proteases (InhA1, InhA2, camelysin, TasA, NprB, and MmpZ). The role of each protease in degradation of the B. anthracis toxin components and ALO was demonstrated. Levels of the anthrax toxin components and ALO in the supernatant of the sporulation defective, pXO1⁺ A35HMS mutant strain deleted for the six proteases were significantly increased and remained stable over 24 h. A pXO1-free variant of this six-protease mutant strain, designated BH460, provides an improved host strain for the preparation of recombinant proteins. As an example, BH460 was used to produce recombinant EF, which previously has been difficult to obtain from B. anthracis. The EF protein produced from BH460 had the highest in vivo potency of any EF previously purified from B. anthracis or Escherichia coli hosts. BH460 is recommended as an effective host strain for recombinant protein production, typically yielding greater than 10mg pure protein per liter of culture. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21827967      PMCID: PMC3183367          DOI: 10.1016/j.pep.2011.05.016

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  35 in total

1.  Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough.

Authors:  Sandriyana Soelaiman; Binqing Q Wei; Pamela Bergson; Young-Sam Lee; Yuequan Shen; Milan Mrksich; Brian K Shoichet; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

2.  Camelysin is a novel surface metalloproteinase from Bacillus cereus.

Authors:  Gregor Grass; Angelika Schierhorn; Eduard Sorkau; Helmut Müller; Peter Rücknagel; Dietrich H Nies; Beate Fricke
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Optimized production and purification of Bacillus anthracis lethal factor.

Authors:  S Park; S H Leppla
Journal:  Protein Expr Purif       Date:  2000-04       Impact factor: 1.650

4.  Heterologous production of Clostridium cellulovorans engB, using protease-deficient Bacillus subtilis, and preparation of active recombinant cellulosomes.

Authors:  Koichiro Murashima; Chyi-Liang Chen; Akihiko Kosugi; Yutaka Tamaru; Roy H Doi; Sui-Lam Wong
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

5.  Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus.

Authors:  C A Pritzlaff; J C Chang; S P Kuo; G S Tamura; C E Rubens; V Nizet
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

6.  The Bacillus thuringiensis PlcR-regulated gene inhA2 is necessary, but not sufficient, for virulence.

Authors:  Sinda Fedhila; Michel Gohar; Leyla Slamti; Patricia Nel; Didier Lereclus
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

7.  Transcriptional regulation of the protective antigen gene of Bacillus anthracis.

Authors:  J M Bartkus; S H Leppla
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

8.  The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria.

Authors:  Timothy D Read; Scott N Peterson; Nicolas Tourasse; Les W Baillie; Ian T Paulsen; Karen E Nelson; Hervé Tettelin; Derrick E Fouts; Jonathan A Eisen; Steven R Gill; Erik K Holtzapple; Ole Andreas Okstad; Erlendur Helgason; Jennifer Rilstone; Martin Wu; James F Kolonay; Maureen J Beanan; Robert J Dodson; Lauren M Brinkac; Michelle Gwinn; Robert T DeBoy; Ramana Madpu; Sean C Daugherty; A Scott Durkin; Daniel H Haft; William C Nelson; Jeremy D Peterson; Mihai Pop; Hoda M Khouri; Diana Radune; Jonathan L Benton; Yasmin Mahamoud; Lingxia Jiang; Ioana R Hance; Janice F Weidman; Kristi J Berry; Roger D Plaut; Alex M Wolf; Kisha L Watkins; William C Nierman; Alyson Hazen; Robin Cline; Caroline Redmond; Joanne E Thwaite; Owen White; Steven L Salzberg; Brendan Thomason; Arthur M Friedlander; Theresa M Koehler; Philip C Hanna; Anne-Brit Kolstø; Claire M Fraser
Journal:  Nature       Date:  2003-05-01       Impact factor: 49.962

9.  Phosphatidylcholine-specific phospholipase C and sphingomyelinase activities in bacteria of the Bacillus cereus group.

Authors:  A P Pomerantsev; K V Kalnin; M Osorio; S H Leppla
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin.

Authors:  Jeffrey G Shannon; Cana L Ross; Theresa M Koehler; Richard F Rest
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more
  33 in total

Review 1.  Occurrence, recognition, and reversion of spontaneous, sporulation-deficient Bacillus anthracis mutants that arise during laboratory culture.

Authors:  Inka Sastalla; Stephen H Leppla
Journal:  Microbes Infect       Date:  2011-11-28       Impact factor: 2.700

2.  Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis.

Authors:  Joseph A Bellanti; Feng-Ying C Lin; Chiayung Chu; Joseph Shiloach; Stephen H Leppla; German A Benavides; Arthur Karpas; Mahtab Moayeri; Chunyan Guo; John B Robbins; Rachel Schneerson
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

3.  Key tissue targets responsible for anthrax-toxin-induced lethality.

Authors:  Shihui Liu; Yi Zhang; Mahtab Moayeri; Jie Liu; Devorah Crown; Rasem J Fattah; Alexander N Wein; Zu-Xi Yu; Toren Finkel; Stephen H Leppla
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

4.  Solid tumor therapy by selectively targeting stromal endothelial cells.

Authors:  Shihui Liu; Jie Liu; Qian Ma; Liu Cao; Rasem J Fattah; Zuxi Yu; Thomas H Bugge; Toren Finkel; Stephen H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-29       Impact factor: 11.205

5.  Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins.

Authors:  Sergey M Bezrukov; Xian Liu; Vladimir A Karginov; Alexander N Wein; Stephen H Leppla; Michel R Popoff; Holger Barth; Ekaterina M Nestorovich
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

6.  Bacillus anthracis Overcomes an Amino Acid Auxotrophy by Cleaving Host Serum Proteins.

Authors:  Austen Terwilliger; Michelle C Swick; Kathryn J Pflughoeft; Andrei Pomerantsev; C Rick Lyons; Theresa M Koehler; Anthony Maresso
Journal:  J Bacteriol       Date:  2015-05-11       Impact factor: 3.490

7.  Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease.

Authors:  Kathryn J Pflughoeft; Michelle C Swick; David A Engler; Hye-Jeong Yeo; Theresa M Koehler
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

8.  Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxel.

Authors:  Alexander N Wein; Shihui Liu; Yi Zhang; Andrew T McKenzie; Stephen H Leppla
Journal:  Invest New Drugs       Date:  2012-07-28       Impact factor: 3.850

9.  Structural Basis for Latency and Function of Immune Inhibitor A Metallopeptidase, a Modulator of the Bacillus anthracis Secretome.

Authors:  Joan L Arolas; Theodoros Goulas; Andrei P Pomerantsev; Stephen H Leppla; F Xavier Gomis-Rüth
Journal:  Structure       Date:  2016-01-05       Impact factor: 5.006

10.  Recombinant expression and purification of a tumor-targeted toxin in Bacillus anthracis.

Authors:  Christopher Bachran; Suzanne Abdelazim; Rasem J Fattah; Shihui Liu; Stephen H Leppla
Journal:  Biochem Biophys Res Commun       Date:  2012-11-27       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.